Table 5.

Predicted probabilities for the compounds to exhibit adverse organ specific health effects (n/a denotes that calculated values are not available) [6].

No	Probability for adverse health effectsa
	Blood	Cardiovascular	Gastrointestinal	Kidney	Liver	Lungs
1	0.57	0.40	0.65 T	0.28	0.48 T	0.34 T
2	0.44	0.34	0.80	0.20	0.18	0.27
3	0.20	0.31	0.26	0.11	0.20 T	0.20 T
4	0.79	0.07	0.92	0.57	0.85	0.74
5	0.76	0.06	0.97	0.75 T	0.93 T	0.71 T
6	0.27	0.12	0.65	0.14	0.05	0.40
7	0.52	0.33	0.83	0.19	0.10	0.17 T
8	0.63	0.06	0.84	0.31	0.05	0.75
9	0.32	0.08	0.90	0.42	0.07	0.72
10	0.53	0.64	0.66	0.14	0.29 T	0.29 T
11	0.19	0.08	0.25	0.09	0.04	0.04 T
12	0.48	0.14	0.71	0.15	0.28	0.42
13	0.47	0.21	0.89	0.18	0.12	0.47
14	n/a	N/a	n/a	n/a	n/a	n/a
15	0.10	0.08	0.81	0.09	0.05	0.27
16	0.14	0.02	0.46	0.03	0.06	0.04
17	0.12	0.02	0.46	0.07	0.02	0.05
18	0.08	0.02	0.36	0.04	0.02	0.05

^a T denotes that tumors have been found in experimental studies